These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 35019671)

  • 1.
    Aragaw WW; Cotroneo N; Stokes S; Pucci M; Critchley I; Gengenbacher M; Dick T
    Microbiol Spectr; 2022 Feb; 10(1):e0132121. PubMed ID: 35019671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.
    Negatu DA; Beuchel A; Madani A; Alvarez N; Chen C; Aragaw WW; Zimmerman MD; Laleu B; Gengenbacher M; Dartois V; Imming P; Dick T
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0067621. PubMed ID: 34001512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus.
    Madani A; Negatu DA; El Marrouni A; Miller RR; Boyce CW; Murgolo N; Bungard CJ; Zimmerman MD; Dartois V; Gengenbacher M; Olsen DB; Dick T
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0066922. PubMed ID: 36005813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
    Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections.
    Talley AK; Thurston A; Moore G; Gupta VK; Satterfield M; Manyak E; Stokes S; Dane A; Melnick D
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0120821. PubMed ID: 34491803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection.
    Cotroneo N; Stokes SS; Pucci MJ; Rubio A; Hamed KA; Critchley IA
    J Antimicrob Chemother; 2024 Apr; 79(4):875-882. PubMed ID: 38394463
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kim DH; Zo S; Kim SY; Jhun BW
    Ann Lab Med; 2024 Jan; 44(1):92-96. PubMed ID: 37665290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria.
    Pennings LJ; Ruth MM; Wertheim HFL; van Ingen J
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudapyridine (WX-081) antibacterial activity against
    Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
    mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Brown-Elliott BA; Rubio A; Wallace RJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of
    Negatu DA; Aragaw WW; Dartois V; Dick T
    Microbiol Spectr; 2023 Aug; 11(4):e0219923. PubMed ID: 37458588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera.
    Pidot SJ; Porter JL; Lister T; Stinear TP
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009636. PubMed ID: 34310615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
    Thapa J; Chizimu JY; Kitamura S; Akapelwa ML; Suwanthada P; Miura N; Toyting J; Nishimura T; Hasegawa N; Nishiuchi Y; Gordon SV; Nakajima C; Suzuki Y
    Microbiol Spectr; 2023 Jun; 11(3):e0508822. PubMed ID: 37067420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of resistance to macrolides and aminoglycosides in Mycobacterium avium, M. abscessus, and M. chelonae identified in the Laboratorio Nacional de Referencia of Colombia from 2018 to 2022.
    Llerena C; Valbuena YA; Zabaleta AP; García AN
    Biomedica; 2024 May; 44(2):182-190. PubMed ID: 39088528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
    Fröberg G; Maurer FP; Chryssanthou E; Fernström L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyryläinen HL; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schön T;
    Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of PBTZ169 and pretomanid against Mycobacterium avium,
    Zheng L; Qi X; Zhang W; Wang H; Fu L; Wang B; Chen X; Chen X; Lu Y
    Front Cell Infect Microbiol; 2023; 13():1115530. PubMed ID: 37077530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.
    Gupta R; Rodrigues Felix C; Akerman MP; Akerman KJ; Slabber CA; Wang W; Adams J; Shaw LN; Tse-Dinh YC; Munro OQ; Rohde KH
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.